Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dermira Inc (DERM)

Dermira Inc (DERM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dermira Inc 275 Middlefield Road Suite150 Menlo Park CA 94025 USA

P: 650-421-7200

Description:

Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients. The Company markets topical small molecule therapeutics that target acne, sebaceous gland hyperactivity, and inflammatory skin diseases. Its late-stage product candidates comprise Cimzia which has completed Phase II clinical trials for the treatment of moderate-to-severe plaque psoriasis; DRM04 that is in a Phase IIb clinical trial for the treatment of hyperhidrosis or excessive sweating; and DRM01 which has completed a Phase IIa clinical trial for the treatment of acne. Dermira, Inc. is headquartered in Redwood City, California.

Key Statistics

Overview:

Market Capitalization, $K 1,022,269
Shares Outstanding, K 54,521
Annual Sales, $ 42,340 K
Annual Net Income, $ -221,540 K
Last Quarter Sales, $ 11,530 K
Last Quarter Net Income, $ -57,620 K
60-Month Beta 1.56
% of Insider Shareholders 12.40%
% of Institutional Shareholders 98.72%
Float, K 47,760
% Float 87.60%

Growth:

1-Year Return 147.04%
3-Year Return -43.52%
5-Year Return 12.07%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -126.84%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 02/25/20
Earnings Per Share ttm -4.58
EPS Growth vs. Prev Qtr -221.21%
EPS Growth vs. Prev Year 32.91%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

DERM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -2.32
Price/Earnings to Growth N/A
Return-on-Equity % -583.07%
Return-on-Assets % -50.25%
Profit Margin % -523.24
Net Margin % N/A
Debt/Equity 25.08
Price/Sales 11.00
Price/Cash Flow N/A
Price/Book 70.44
Book Value/Share 0.27
Interest Coverage -13.18
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar